Cytochroma manufacture genetically diverse stem cell to predict the safety and effect of drugs .
Cytochroma has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in December 2021.
Cytochroma's investors include Scottish Enterprise, Innovate UK, Angel Academe, Investing Women, Cambridge Capital Group.
Cytochroma is headquartered in Edinburgh, United Kingdom.
Cytochroma manufacture genetically diverse stem cell to predict the safety and effect of drugs .
Cytochroma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cytochroma — Funding & Investors." VCBacked, December 16, 2021, https://www.vcbacked.co/company/cytochroma. Accessed August 15, 2026.
VCBacked. (2021). Cytochroma — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/cytochroma
{{cite web |title=Cytochroma — Funding & Investors |url=https://www.vcbacked.co/company/cytochroma |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated